TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6777653

Group type: EXPERIMENTAL
Intervention: Intravenous hyperalimentation (IVH)
Number of subjects: 0
Study: 30895944

Group type: EXPERIMENTAL
Intervention: Topical calcipotriol plus 5‐fluorouracil (5‐FU)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Vaseline plus 5‐fluorouracil (5‐FU) (control)
Number of subjects: 70
Study: 28755244

Group type: EXPERIMENTAL
Intervention: 5-min quitting advice from youth counselors and a 12-page self-help smoking cessation booklet
Number of subjects: 831

Group type: COMPARATOR
Intervention: 12-page self-help smoking cessation booklet
Number of subjects: 831
Study: 26490488

Group type: EXPERIMENTAL
Intervention: Communication training for postgraduate physicians, duration: three days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 25237122

Group type: EXPERIMENTAL
Intervention: 10 mg oxycodone
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 20 mg oxycodone
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 22641495

Group type: EXPERIMENTAL
Intervention: Varicocele repair (varicocelectomy)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Expectant therapy
Number of subjects: 136
Study: 20078852

Group type: EXPERIMENTAL
Intervention: Feedback Training System for home rehabilitation
Number of subjects: 46

Group type: COMPARATOR
Intervention: Standard physiotherapeutic training
Number of subjects: 46
Study: 17651518

Group type: EXPERIMENTAL
Intervention: TRL derived from high-oleic sunflower oil (HOSO)
Number of subjects: 9

Group type: COMPARATOR
Intervention: TRL derived from virgin olive oil (VOO)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: TRL derived from virgin olive oil enriched with minor components (EVO)
Number of subjects: 9
Study: 15850733

Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo acupuncture
Number of subjects: 14

Group type: COMPARATOR
Intervention: Skin prick
Number of subjects: 14
Study: 12417866

Group type: EXPERIMENTAL
Intervention: Systemic glucocorticoids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 10611883

Group type: EXPERIMENTAL
Intervention: Naproxen 750 mg per day
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Indomethacin 75 mg per day
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Naproxen, Indomethacin, Placebo
Number of subjects: 84
Study: 7727328

Group type: EXPERIMENTAL
Intervention: Isobaric tetracaine (IT) at varying doses and volumes
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Isobaric tetracaine (IT) at constant volume
Number of subjects: 120
Study: 2328752

Group type: EXPERIMENTAL
Intervention: Enzyme potentiated desensitising vaccine (single injection in March)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 7011357

Group type: EXPERIMENTAL
Intervention: Combination of chlorpheniramine and cimetidine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Chlorpheniramine alone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cimetidine alone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 29177920

Group type: EXPERIMENTAL
Intervention: Targeted, low-literacy intervention (photonovella and DVD plus fecal immunochemical test [FIT])
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Non-targeted intervention (standard educational brochure plus FIT)
Number of subjects: 270
Study: 27824234

Group type: EXPERIMENTAL
Intervention: Arm aerobic exercise (3 days/week; 1.5 hours/week at 50‐70% pVO2) for 12 weeks
Number of subjects: 33

Group type: COMPARATOR
Intervention: General exercises only (2 sessions/day; 5 days/week)
Number of subjects: 33
Study: 26717366

Group type: EXPERIMENTAL
Intervention: Sunitinib (25mg qd for 10 days between cycles) combined with docetaxel (40 mg) and cisplatin (50 mg) for 12 cycles (24 weeks) followed by maintenance vinorelbine (30mg TIW) until disease progression
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sunitinib combined with chemotherapy
Number of subjects: 6
Study: 26227903

Group type: EXPERIMENTAL
Intervention: Electronic hormonal fertility monitor (EHFM)
Number of subjects: 357

Group type: COMPARATOR
Intervention: Cervical mucus monitoring (CMM)
Number of subjects: 357
Study: 22577293

Group type: EXPERIMENTAL
Intervention: Food supplement 20070721-GX
Number of subjects: 44
Study: 19485723

Group type: EXPERIMENTAL
Intervention: 5% lidocaine medicated plaster
Number of subjects: 300

Group type: COMPARATOR
Intervention: Pregabalin
Number of subjects: 300
Study: 18949216

Group type: EXPERIMENTAL
Intervention: 60 mg/kg PZQ + 6 mg/kg AM
Number of subjects: 0

Group type: COMPARATOR
Intervention: 60 mg/kg PZQ + AM placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 120 mg/kg PZQ + 6 mg/kg AM
Number of subjects: 0

Group type: COMPARATOR
Intervention: 120 mg/kg PZQ + AM placebo
Number of subjects: 0
Study: 15691272

Group type: EXPERIMENTAL
Intervention: FK506 0.06% three times per day for 6 months
Number of subjects: 40

Group type: COMPARATOR
Intervention: Prednisolone acetate 1% tapered within 6 months
Number of subjects: 40
Study: 12073766

Group type: EXPERIMENTAL
Intervention: Heparan sulfate (40 mg orally twice a day)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Heparan sulfate
Number of subjects: 217
Study: 10432913

Group type: EXPERIMENTAL
Intervention: Postcard reminder intervention group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no postcard)
Number of subjects: 0
Study: 7719178

Group type: EXPERIMENTAL
Intervention: Tricyclic antidepressants
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2396469

Group type: EXPERIMENTAL
Intervention: Vero OPV
Number of subjects: 305

Group type: COMPARATOR
Intervention: PMK OPV
Number of subjects: 305
Study: 32007

Group type: EXPERIMENTAL
Intervention: Chlorothiazide twice a day plus atenolol, metoprolol, pindolol and propranolol in single daily doses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Each beta‐adrenoreceptor‐blocking drug
Number of subjects: 0
Study: 30649176

Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1000 mg Ca/d)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 28429343

Group type: COMPARATOR
Intervention: McDonald's® Meal (McDM)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: McDonald's® Meal (McDM) + Hazelnut (H)
Number of subjects: 22

Group type: COMPARATOR
Intervention: No Dietary Treatment (NDT)
Number of subjects: 22
Study: 26362830

Group type: EXPERIMENTAL
Intervention: Renal denervation (RDN)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 134
Study: 23700341

Group type: EXPERIMENTAL
Intervention: Maternal weight loss (BMI < 18 kg/m²)
Number of subjects: 1309

Group type: COMPARATOR
Intervention: No weight loss (BMI ≥ 18 kg/m²)
Number of subjects: 1309
Study: 21881528

Group type: EXPERIMENTAL
Intervention: Amlodipine ± Perindopril
Number of subjects: 3666

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 3666

Group type: EXPERIMENTAL
Intervention: Previous use of aspirin
Number of subjects: 3666

Group type: EXPERIMENTAL
Intervention: Baseline SBP strata (151-160, 161-170, 171-180, >180 mmHg)
Number of subjects: 3666

Group type: EXPERIMENTAL
Intervention: Risk score developed
Number of subjects: 3666
Study: 19664426

Group type: EXPERIMENTAL
Intervention: BAC level 0.08%
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: BAC level 0.05%
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High task demand (offset weave)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High time pressure (hazard avoidance for near obstacles)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Constrained tolerances (circuit track)
Number of subjects: 24
Study: 17938794

Group type: EXPERIMENTAL
Intervention: Bolus infusion (BI) of rFVIIa (90 microg/kg every 2 hours during surgery through day 5, then every 4 hours for days 6-10)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Continuous infusion (CI) of rFVIIa (50 microg/kg/h through day 5, then 25 microg/kg/h for days 6-10)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group receiving FVIII or FIX concentrates
Number of subjects: 24
Study: 15359923

Group type: EXPERIMENTAL
Intervention: Tc‐99m DTPA aerosol lung scintigraphy in PSP patients
Number of subjects: 13

Group type: COMPARATOR
Intervention: Tc‐99m DTPA aerosol lung scintigraphy in healthy controls
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Tc‐99m DTPA aerosol lung scintigraphy in apical parts of lungs
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Tc‐99m DTPA aerosol lung scintigraphy in basal parts of lungs
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Correlation analysis of clearance rate of Tc‐99m DTPA with PFT results
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Correlation analysis of clearance rate of Tc‐99m DTPA with recurrence rate of PSP
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Correlation analysis of clearance rate of Tc‐99m DTPA with percentage of pneumothorax
Number of subjects: 13
Study: 11780862

Group type: EXPERIMENTAL
Intervention: Repinotan (0.5 mg/day)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Repinotan (1.25 mg/day)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Repinotan (2.50 mg/day)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Repinotan (various doses)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 9761783

Group type: EXPERIMENTAL
Intervention: Carotenoid supplementation for 12 weeks
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Men from Ireland and the U.K.
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Women from all five countries
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Correlation between mean levels of 8-oxo-dG and coronary heart disease mortality in men
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Colorectal cancer in men
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Stomach cancer in women
Number of subjects: 9
Study: 7797214

Group type: EXPERIMENTAL
Intervention: Metoprolol (50-100 mg per day)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 3044068

Group type: EXPERIMENTAL
Intervention: High sucrose diet (220 g of sucrose daily)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Complex carbohydrate (CHO) diet (less than 3 g of sucrose daily)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High sucrose diet (220 g of sucrose daily) in patients with preexisting higher triglyceridemia
Number of subjects: 18
Study: 31909680

Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) 300 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 30689551

Group type: EXPERIMENTAL
Intervention: Ai Chi
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Bad Ragaz Ring Method (BRRM)
Number of subjects: 44
Study: 29149869

Group type: EXPERIMENTAL
Intervention: Breastfeeding without nipple shield
Number of subjects: 38

Group type: COMPARATOR
Intervention: Breastfeeding with nipple shield
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Longer sucking duration
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Greater proportion of feed sucked
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Greater sucking efficiency
Number of subjects: 38
Study: 26602302

Group type: EXPERIMENTAL
Intervention: Interventions related to sanitation, hygiene, and infant nutrition as part of the SHINE trial.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 24341382

Group type: EXPERIMENTAL
Intervention: AZD8309 (300 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 21495995

Group type: EXPERIMENTAL
Intervention: Oral lymecycline 300 mg with adapalene 0.1%-BPO 2.5% (A/BPO)
Number of subjects: 378

Group type: COMPARATOR
Intervention: Oral lymecycline 300 mg with vehicle gel
Number of subjects: 378
Study: 18430831

Group type: EXPERIMENTAL
Intervention: Continuous catheter drainage with negative pressure
Number of subjects: 85

Group type: COMPARATOR
Intervention: Single-session alcohol sclerotherapy
Number of subjects: 85
Study: 16484584

Group type: EXPERIMENTAL
Intervention: Fludarabine and high-dose cytosine (FLA)
Number of subjects: 405

Group type: COMPARATOR
Intervention: Standard chemotherapy (ADE)
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Addition of G-CSF
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Addition of ATRA
Number of subjects: 405
Study: 12916867

Group type: EXPERIMENTAL
Intervention: BEAC
Number of subjects: 71

Group type: COMPARATOR
Intervention: BEAM
Number of subjects: 71
Study: 10883411

Group type: EXPERIMENTAL
Intervention: Lecture supplemented by symbolic slides
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lecture without symbolic slides
Number of subjects: 40
Study: 9347673

Group type: COMPARATOR
Intervention: Diclofenac emulgel, applied at the painful site four times a day for 4 weeks
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Ketoprofen hydroalcoholic gel, applied at the painful site four times a day for 4 weeks
Number of subjects: 85
Study: 8212152

Group type: EXPERIMENTAL
Intervention: Short taper group (total PRED dose of 2275 mg/m2 over 86 days)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Long taper group (total PRED dose of 6300 mg/m2 over 147 days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 30
Study: 3757605

Group type: EXPERIMENTAL
Intervention: Dispositional information (because he's real nice) for 9-year-olds
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Situational information (because he has a new game) for 9-year-olds
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Situational information (because he has a new game) for younger age groups (5 1/2 and 7 years old)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Dispositional information (because he's real nice) for younger age groups (5 1/2 and 7 years old)
Number of subjects: 3
Study: 30121072

Group type: EXPERIMENTAL
Intervention: Intraoperative GDFT guided by PVI, administering fluid boluses of 3 ml/kg tetrastarch aiming at a PVI value below 10%.
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group using esophageal Doppler for GDFT aiming for optimization of stroke volume.
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: PVI group
Number of subjects: 150

Group type: COMPARATOR
Intervention: Doppler group
Number of subjects: 150
Study: 27359176

Group type: EXPERIMENTAL
Intervention: 1-year multicomponent behavioral intervention
Number of subjects: 111

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 111
Study: 25722222

Group type: EXPERIMENTAL
Intervention: Basal insulin therapy with glargine
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Basal insulin therapy with detemir
Number of subjects: 42

Group type: COMPARATOR
Intervention: Hypoglycemia episodes
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Changes in EPCs
Number of subjects: 42
Study: 22840617

Group type: EXPERIMENTAL
Intervention: TAU + SCIT (n=21)
Number of subjects: 37

Group type: COMPARATOR
Intervention: TAU (n=16)
Number of subjects: 37
Study: 19828484

Group type: EXPERIMENTAL
Intervention: High magnesium levels (>1.0 mmol/l)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Normal magnesium levels (<=1.0 mmol/l)
Number of subjects: 108
Study: 17984189

Group type: EXPERIMENTAL
Intervention: Glutamine (Gln) supplementation (100 mg kg(‐1) body weight)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Alanine (Ala) supplementation (100 mg kg(‐1) body weight)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Glutamine (Gln) supplementation (once a day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Long-term Glutamine (Gln) supplementation
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Glutamine (Gln) and Alanine (Ala) supplementation
Number of subjects: 30
Study: 15793367

Group type: EXPERIMENTAL
Intervention: Lamivir (Cipla, Mumbai, India)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Epivir (GSK, Basingstoke, UK)
Number of subjects: 24
Study: 14578253

Group type: EXPERIMENTAL
Intervention: 30 mg/day pioglitazone
Number of subjects: 39

Group type: COMPARATOR
Intervention: Diet and exercise program
Number of subjects: 39
Study: 10986000

Group type: EXPERIMENTAL
Intervention: Acupuncture (20 treatments over 8 weeks)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sham acupuncture (20 treatments over 8 weeks)
Number of subjects: 34
Study: 8635374

Group type: EXPERIMENTAL
Intervention: Mitomycin, vinblastine, and cisplatin
Number of subjects: 133

Group type: COMPARATOR
Intervention: Mitomycin alone
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Mitomycin therapy
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Corticosteroid therapy
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Mitomycin
Number of subjects: 133
Study: 1514487

Group type: EXPERIMENTAL
Intervention: Single-port infusion protocol
Number of subjects: 140

Group type: COMPARATOR
Intervention: Double-port infusion protocol
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Single-port and double-port protocols
Number of subjects: 140
Study: 6487499

Group type: EXPERIMENTAL
Intervention: Enprofylline at plasma concentrations of 1.5 micrograms/ml
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Enprofylline at plasma concentrations of 2.9 micrograms/ml
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Enprofylline at plasma concentrations of 4.0 micrograms/ml
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Theophylline at plasma concentrations of 5.5 micrograms/ml
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Theophylline at plasma concentrations of 10.8 micrograms/ml
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Theophylline at plasma concentrations of 15.2 micrograms/ml
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Enprofylline (above 2.9 micrograms/ml)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Theophylline infusion
Number of subjects: 20
Study: 30765435

Group type: EXPERIMENTAL
Intervention: IONIS‐GCGRRx 200 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IONIS‐GCGRRx 100 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IONIS‐GCGRRx 75 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IONIS‐GCGRRx 50 mg
Number of subjects: 0
Study: 29244746

Group type: EXPERIMENTAL
Intervention: Beetroot juice (70 mL, 5.6 mmol NO₃‐)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 26445182

Group type: EXPERIMENTAL
Intervention: Semiclosed hemorrhoidectomy
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Stapled hemorrhoidectomy
Number of subjects: 180

Group type: COMPARATOR
Intervention: Open hemorrhoidectomy
Number of subjects: 180
Study: 24402698

Group type: EXPERIMENTAL
Intervention: High working memory capacity group
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Low working memory capacity group
Number of subjects: 2

Group type: COMPARATOR
Intervention: Overall WMC groups
Number of subjects: 2
Study: 23051880

Group type: EXPERIMENTAL
Intervention: Video distraction (video clip of child's preference during induction)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Traditional distraction methods (control group)
Number of subjects: 89
Study: 19364250

Group type: EXPERIMENTAL
Intervention: Subcutaneous apomorphine co-administered with trimethobenzamide or domperidone premedication
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Subcutaneous infusion of apomorphine
Number of subjects: 0
Study: 17707934

Group type: EXPERIMENTAL
Intervention: Group-randomized trials
Number of subjects: 0
Study: 15024927

Group type: EXPERIMENTAL
Intervention: Supervised treatment with primaquine (0.25 mg PQ/kg body weight) once per day for 14 days
Number of subjects: 595

Group type: EXPERIMENTAL
Intervention: Unsupervised treatment with primaquine (14 doses provided upon enrollment)
Number of subjects: 595

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 595
Study: 15960211

Group type: EXPERIMENTAL
Intervention: Diclofenac intramuscular single dose
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both groups received morphine by Patient Controlled Analgesia (PCA)
Number of subjects: 64
Study: 10494364

Group type: EXPERIMENTAL
Intervention: Active warming (WarmTouch 5000, 41-42 degrees C)
Number of subjects: 54

Group type: COMPARATOR
Intervention: No active warming
Number of subjects: 54
Study: 8739682

Group type: EXPERIMENTAL
Intervention: 0.5% timolol solution given twice daily
Number of subjects: 223

Group type: COMPARATOR
Intervention: 0.5% timolol in gel‐forming solution given once daily
Number of subjects: 223

Group type: EXPERIMENTAL
Intervention: 0.5% timolol in gel‐forming solution
Number of subjects: 223

Group type: COMPARATOR
Intervention: 0.5% timolol solution
Number of subjects: 223
Study: 1890650

Group type: EXPERIMENTAL
Intervention: B2 agonists kallidin
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: B2 agonists bradykinin
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: [Des-Arg9]-bradykinin (B1 agonist)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Vehicle placebo
Number of subjects: 14
Study: 6125727

Group type: EXPERIMENTAL
Intervention: Potassium supplementation (60 mmol/day)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 30550313

Group type: EXPERIMENTAL
Intervention: Self-regulation with large changes (LC)
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Self-regulation with small changes (SC)
Number of subjects: 599

Group type: COMPARATOR
Intervention: Self-regulation interventions (both SC and LC)
Number of subjects: 599

Group type: EXPERIMENTAL
Intervention: Greater self-weighing frequency
Number of subjects: 599
Study: 30009127

Group type: EXPERIMENTAL
Intervention: tDCS over the left inferior frontal gyrus (IFG)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 24
Study: 27247173

Group type: EXPERIMENTAL
Intervention: Employment
Number of subjects: 2055

Group type: COMPARATOR
Intervention: Unemployed
Number of subjects: 2055
Study: 24979307

Group type: EXPERIMENTAL
Intervention: Azelnidipine
Number of subjects: 14

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 14